Century Therapeutics Stock Probability of Future Stock Price Finishing Under 3.02
| IPSC Stock | USD 1.01 0.01 1.00% |
Century |
Century Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Century Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Century Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Century Therapeutics generated a negative expected return over the last 90 days | |
| Century Therapeutics has high historical volatility and very poor performance | |
| Century Therapeutics has some characteristics of a very speculative penny stock | |
| Century Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.23 M. Net Loss for the year was (136.67 M) with profit before overhead, payroll, taxes, and interest of 5.2 M. | |
| Century Therapeutics currently holds about 378.76 M in cash with (88.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.43, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Century Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 61.0% of the company shares are owned by institutional investors |
Century Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Century Stock often depends not only on the future outlook of the current and potential Century Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Century Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.3 M | |
| Cash And Short Term Investments | 172.7 M |
Century Therapeutics Technical Analysis
Century Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Century Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Century Therapeutics. In general, you should focus on analyzing Century Stock price patterns and their correlations with different microeconomic environments and drivers.
Century Therapeutics Predictive Forecast Models
Century Therapeutics' time-series forecasting models is one of many Century Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Century Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Century Therapeutics
Checking the ongoing alerts about Century Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Century Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Century Therapeutics generated a negative expected return over the last 90 days | |
| Century Therapeutics has high historical volatility and very poor performance | |
| Century Therapeutics has some characteristics of a very speculative penny stock | |
| Century Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.23 M. Net Loss for the year was (136.67 M) with profit before overhead, payroll, taxes, and interest of 5.2 M. | |
| Century Therapeutics currently holds about 378.76 M in cash with (88.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.43, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Century Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 61.0% of the company shares are owned by institutional investors |
Check out Century Therapeutics Backtesting, Century Therapeutics Valuation, Century Therapeutics Correlation, Century Therapeutics Hype Analysis, Century Therapeutics Volatility, Century Therapeutics History as well as Century Therapeutics Performance. For information on how to trade Century Stock refer to our How to Trade Century Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Century Therapeutics. If investors know Century will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Century Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Century Therapeutics is measured differently than its book value, which is the value of Century that is recorded on the company's balance sheet. Investors also form their own opinion of Century Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Century Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Century Therapeutics' market value can be influenced by many factors that don't directly affect Century Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Century Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Century Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Century Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.